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iTATE-OF-THE-ART PAPER1741Syncopeavid G. Benditt, John T. Nguyen
yncope is a common clinical problem characterized by transient, spontaneously self-
erminating loss of consciousness with complete and prompt recovery. The cause is most often
ue to a transient fall of systemic arterial pressure below the threshold for cerebrovascular
utoregulation. This review by Benditt and Nguyen advises that a careful and thorough
valuation is warranted in all patients with syncope, but acknowledges that the diagnostic
valuation and treatment of syncope is challenging. The evidence regarding many
ecommended therapies is reviewed and is found to be less than conclusive for most therapies.CARDIOVASCULAR
GENOMIC MEDICINEARDIOVASCULAR GENOMIC MEDICINE1752Genomics, Transcriptional Profiling, and Congestive Heart Failureenneth B. Margulies, Daniel P. Bednarik, Daniel L. Dries
argulies and colleagues provide an overview of the role of genomics for both better
nderstanding of disease progression and tailoring of therapy to the individual. For instance,
he identification of mutations causing hereditary hypertrophic and dilated cardiomyopathies
as provided both pathophysiological insights and clinically applicable diagnostics. Genotyping
linical trial participants and genome-wide association studies have accelerated the
dentification of disease- and treatment-modifying genes. At the same time, increasingly
etailed characterization of gene expression within diseased tissues is providing new insights
nto the pathophysiology of heart failure.(continued on page A-23)
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pNTERVENTIONAL CARDIOLOGY1760Similar Outcomes for Left Main Stenting With PES or SESEditorial Commentulinda Mehilli, Adnan Kastrati, Robert A. Byrne, Olga Bruskina, Raisuke Iijima, Stefanie Schulz,
ürgen Pache, Melchior Seyfarth, Steffen Maßberg, Karl-Ludwig Laugwitz, Josef Dirschinger, Albert Schömig,
or the ISAR-LEFT-MAIN (Intracoronary Stenting and Angiographic Results: Drug-Eluting Stents
or Unprotected Coronary Left Main Lesions) Study Investigators
ehilli and colleagues report the results of the ISAR-LEFT-MAIN study, which
andomized over 600 patients with unprotected left main coronary artery (uLMCA) stenosis
ho were unable or unwilling to undergo surgical revascularization to either a paclitaxel-
luting stent (PES) or a sirolimus-eluting stent (SES). There was no difference in the primary
nd point, which was a composite of death, myocardial infarction, and target lesion
evascularization at 1 year. The secondary end point of angiographic restenosis was also
imilar at follow-up angiography. Definite stent thrombosis occurred in 3 patients (0.5%) and
-year mortality was similar at approximately 10%. Implantation of either a PES or SES in
LMCA lesions appears to be safe with no clear advantage to either stent.NTERVENTIONAL CARDIOLOGY1773Benefits of DES Seen for Both Off- and On-Label Indications0.8
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3ennis T. Ko, Maria Chiu, Helen Guo, Peter C. Austin, Ron Goeree, Eric Cohen,
arino Labinaz, Jack V. Tu
o and colleagues evaluated the long-term safety and efficacy of drug-eluting stents (DES)
ompared with bare-metal stents (BMS) stratified according to whether the stent
mplantation complied with the Food and Drug Administration labeling restrictions for DES.
ropensity score matching analysis was performed in a large population-based cohort. For
atients with off-label indications, both mortality and target vessel revascularization (TVR)
ere significantly lower for DES patients. For patients with on-label indications, DES was
ssociated with reduced TVR but there was no difference in mortality or subsequent
yocardial infarction. This analysis confirms that DES reduce TVR compared with BMS; in
atients with off-label indications, DES may also improve mortality.(continued on page A-25)
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1783ew Assay for ANP Superior to BNP for Predicting Death in Patients With
Chronic HFeddo Moertl, Rudolf Berger, Joachim Struck, Andreas Gleiss, Alexandra Hammer,
ils G. Morgenthaler, Andreas Bergmann, Martin Huelsmann, Richard Pacher
trial natriuretic peptides (ANPs) and B-type natriuretic peptides (BNPs) have similar
hysiologic characteristics, but previous ANP assays had an inferior prognostic performance
ompared with BNP. Moertl and colleagues studied a new ANP assay that targets the
idregion (MR) of the pro-peptide rather than the N-terminal (NT) because the NT may
e subject to terminal truncations. MR-proANP, BNP, and NT-proBNP levels were
easured in almost 800 patients with chronic heart failure (HF). All 3 assays showed similar
fficacy for detection of a left ventricular ejection fraction 40%. All 3 assays predicted the
isk of death, but the proportion of explained variation was highest for MR-proANP. MR-
roANP may be better than the BNP assays at predicting mortality in patients with HF.EART RHYTHM DISORDERS1791Cardiomyopathy Secondary to Focal AT: Incidence and Treatmentaroline Medi, Jonathan M. Kalman, Haris Haqqani, Jitendra K. Vohra, Joseph B. Morton,
aul B. Sparks, Peter M. Kistler
edi and colleagues studied the incidence of tachycardia-mediated cardiomyopathy (TCM)
econdary to focal atrial tachycardia (AT) by reviewing echocardiograms from 331 patients
eferred for electrophysiologic treatment of AT. Ten percent of subjects had TCM with an
jection fraction 50%. Subjects with TCM were younger and more likely to be male; they
ere also more likely to have incessant or very frequent AT and a slower ventricular rate
uring AT (117 beats/min vs. 141 beats/min). After successful ablation, left ventricular
unction returned to normal in 97% of patients. TCM occurs fairly frequently in patients with
ncessant AT but is reversible.EART RHYTHM DISORDERS1798Fatal Complications of Catheter Ablation of AFEditorial Commenticcardo Cappato, Hugh Calkins, Shih-Ann Chen, Wyn Davies, Yoshito Iesaka, Jonathan Kalman,
ou-Ho Kim, George Klein, Andrea Natale, Douglas Packer, Allan Skanes
appato and colleagues attempted to identify every fatal complication of ablation procedures
or atrial fibrillation (AF) by mailing questionnaires to all centers that performed this
rocedure worldwide. Thirty-two deaths were reported from over 45,000 procedures (0.98 per
,000 patients). Causes of death included tamponade in 8 patients, stroke in 5 patients,
trioesophageal fistula in 5 patients, and massive pneumonia in 2 patients, along with 12
ther complications. Death is a possible but rare complication of catheter ablation of AF,
ccurring in 1 of 1,000 patients.(continued on page A-30)
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1807hite Matter Injuries Often Found in Patients With Complex Congenital
Heart DefectsEditorial Commentohn Beca, Julia Gunn, Lee Coleman, Ayton Hope, Laura-Clare Whelan, Thomas Gentles, Terrie Inder,
od Hunt, Lara Shekerdemian
he surgical repair for transposition of the great arteries (TGA) has low mortality, but
ongitudinal follow-up studies have found that neurodevelopmental and learning difficulties
ften follow. Beca and colleagues performed brain magnetic resonance imaging scans on
4 patients with complex congenital heart defects prior to surgical repair. Brain injury,
redominantly white matter injury, was found in 30% of infants. Strokes were uncommon.
he rates and pattern of injury were similar in patients with TGA, hypoplastic left heart, and
ulmonary atresia. There was no association between brain injury and balloon atrial
eptostomy (BAS). These results suggest that brain injury is related to the heart defect rather
han to BAS or the corrective surgery.PRE-CLINICAL RESEARCH RE-CLINICAL RESEARCH1814Recruitment of Bone Marrow Cells Underlies Benefit of IPCakahiro Kamota, Tao-Sheng Li, Noriyasu Morikage, Masanori Murakami, Mako Ohshima,
asayuki Kubo, Toshiro Kobayashi, Akihito Mikamo, Yasuhiro Ikeda, Masunori Matsuzaki,
imikazu Hamano
amota and colleagues investigated whether the mobilization and recruitment of bone
arrow stem cells (BMSCs) contributes to the cardioprotection found with ischemic pre-
onditioning (IPC). IPC was created with temporary occlusion and reperfusion of the
bdominal aorta in mice that had undergone a bone marrow transplant, such that their
MSCs produced green fluorescent protein. Heart ischemia/reperfusion (I/R) injury was
nduced by occluding the left anterior descending artery for 30 min. BMSCs were recruited
nto the myocardium after IPC and I/R; antibodies against BMSCs significantly attenuated
he positive effects of IPC. Enhanced mobilization and recruitment of BMSCs plays an
mportant role in the protective effects of IPC.
